Back to results
US 10,864,182 B2Granted
Treatment of fragile X syndrome
AssigneeHealx Limited
InventorDavid Brown
Life of this patent
Estimating the term…
Abstract
Described herein is the use of sulindac in the treatment of fragile X syndrome (FXS).
Claims17
A method of treating fragile x syndrome comprising administering to a subject in need thereof a therapeutically effective amount of sulindac or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.